EAST GRINSTEAD, England, June 18 /PRNewswire/ -- Diskeeper Corporation revealed findings of a recent IT study showing Defragmentation and Antivirus as the two most important practices for IT administrators.

A panel of 179 Network Administrators was surveyed recently on the software they considered vital to have on their Servers: 48% responded with "Antivirus/Symantec" and 45%, "Defrag/Diskeeper".

SINGAPORE, June 18 /PRNewswire/ --

- Joikusoft Wins Grand Prize in Annual Location-Based Developers' Program

NAVTEQ (NYSE: NVT), a leading global provider of digital map data for location-based solutions and vehicle navigation, announced yesterday during an awards ceremony at CommunicAsia 2008 that Joikusoft is the Grand Prize Winner of this year's NAVTEQ Global LBS Challenge -- Asia-Pacific (APAC).

PARIS, June 18 /PRNewswire/ -- Valeo announced today that it has signed an agreement for the creation of a joint venture for the production of HVAC (heating, ventilation and air-conditioning) systems with Itelma, a Russian supplier of automotive systems to Russian automakers. The new company, Valeo Climate Control Tomilino LLC, will be 95% owned by Valeo and 5% by Itelma.

Located in Tomilino (10 km from Moscow), the joint venture will develop, produce and sell Valeo Climate Control products and systems, including HVAC modules for passenger cars.

TORONTO, June 18 /PRNewswire/ --

- RedACCESS(TM) AN-80i Solution Provides Cost Savings and Enhanced Reliability and Security to Connect Multiple Court Buildings in El Salvador, Central America

Redline Communications Group Inc. (TSX and AIM: RDL), a leading provider of standards-based WiMAX access and broadband wireless infrastructure products, today announced that Fiscalia General de la Republica (FGR) in El Salvador has chosen Redline's award-winning RedACCESS(TM) AN-80i broadband wireless point-to-multipoint infrastructure solution, to connect its court buildings in San Salvador.

NEW YORK, June 18 /PRNewswire/ --

- Streamlines Debt Structure, Enhances Financial Flexibility for Growth -

Landis+Gyr, the global leader in energy management offering utilities next generation "smart grid" solutions, today announced the conclusion of a new USD 1.1 billion (euro 710 million) refinancing package, bolstering the company's future growth plans.

The new five-year, multi-currency refinancing package replaces two previous bank facilities. A consortium of 13 international banks provided the new facility, which includes term debt, capital expenditure and bonding, as well as working capital tranches.

LEUVEN, Belgium, LUND, Sweden and BASEL, Switzerland, June 18 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR) and BioInvent International AB (Nordic Exchange: BINV) announce that they have entered into a license agreement with Roche (SWX: ROG) for their jointly developed anti-cancer agent TB-403. TB-403 is a novel monoclonal antibody which blocks Placental Growth Factor (PIGF), one of the growth factors responsible for the development of new blood vessels.

It's an ingredient found in dandruff shampoos and, if you're a movie buff, you also know it was used to help fight off alien invaders in the film "Evolution."

Scientists at the University of Leicester are now using selenium as a tool in investigating how the oxygen content of the oceans has changed over geologically recent time.

Selenium is an anti-oxidant and an essential trace nutrient in our diet. It belongs to a group of elements whose behavior is controlled by the concentration of oxygen in the environment. Now scientists are using selenium as part of a research project to measure the isotopic ratios of selenium in sediments.

Between 54 percent and 64 percent of hospitals had chaplaincy services between 1980 and 2003, despite changes over the last fifteen years in national accreditation guidelines making the religious and spiritual care of hospitalized patients a right.

This protection seems to have had no effect on the number of hospitals with chaplains and there was no systematic trend over this period.

Interesting results:

Could injecting a gene into a patient with severe heart failure reverse their disabling and life-threatening condition? Physician-scientists are setting out to answer that question in a first-ever clinical trial of gene therapy to treat severe heart failure.

NewYork-Presbyterian Hospital/Columbia University Medical Center is the only center in the New York City area where the therapy is currently available.

Patients enrolled in the multicenter CUPID trial (Calcium Up-Regulation by Percutaneous Administration of Gene Therapy in Cardiac Disease) will undergo a minimally invasive cardiac catheterization procedure that will introduce a specially engineered gene that stimulates production of an enzyme necessary for the heart to pump more efficiently.

The International Council for Industrial and Applied Mathematics (ICIAM), the International Mathematical Union (IMU) and the Institute of Mathematical Statistics (IMS) today released the Citation Statistics report. The report is written from a mathematical perspective and states that while citation-based statistics such as impact factor are often used to assess scientific research they are not the best measures of research quality.

The use of citations in assessing research quality is a topic that is of increasing interest throughout the world's scientific community. The report cautions against the over-reliance on citation statistics such as the impact factor and h-index. These are often promoted because of the belief in their accuracy, objectivity, and simplicity, but these beliefs are unfounded.

Among the report’s key findings: